BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, June 17, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for Dec. 4, 2023

Dec. 4, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Apogepha Arzneimittel, Benchmark Electronics, Guardant, Nanovibronix, Personalis, Titan Medical.
Read More

Other news to note for Dec. 1, 2023

Dec. 1, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aexon, Cerecin, CNX, Ligand, Maat, Navidea, NLS, Palvella, Pharmnovo, Sanofi.
Read More

Other news to note for Dec. 1, 2023

Dec. 1, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Clarius, Fujirebio, Glucotrak, Naveris, Nevro, Sysmex, Thermo Fisher.
Read More

Other news to note for Dec. 1, 2023

Dec. 1, 2023
Additional early-stage research and drug discovery news in brief, from: Inmune Bio, Quralis.
Read More

Other news to note for Nov. 30, 2023

Nov. 30, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acelyrin, Fortrea, Intas, Johnson & Johnson, Obseva, Roche, Samsung Bioepis, Shape, Sanofi, Teva, Tiziana.
Read More

Other news to note for Nov. 30, 2023

Nov. 30, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Fresnius, Lunit, Procyrion, NTT Data, Ossdsign, Philips, Syntheticmr.
Read More

Other news to note for Nov. 29, 2023

Nov. 29, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abellera, Adaptimmune, Arecor, Ascendis, Eli Lilly, Generation, GSK, Kazia, Moderna, Orlance, Prism, Teijin, Timber.
Read More

Other news to note for Nov. 29, 2023

Nov. 29, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ennocure, Inspira, Penumbra, Plaquetech, Revalve, Trinity Biotech.
Read More

Other news to note for Nov. 29, 2023

Nov. 29, 2023
Additional early-stage research and drug discovery news in brief, from: Clearmind Medicine, Scisparc.
Read More

Other news to note for Nov. 28, 2023

Nov. 28, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: AAX, Accutar, Anaptysbio, Biomarin, Candel, Centessa, DMK, Emergent, Ensysce, Evommune, Fusion, Karuna, Oblique, Oncozenge, Sutro, US Worldmeds, Vaxcyte, Vivus.
Read More
Previous 1 2 … 141 142 143 144 145 146 147 148 149 … 1400 1401 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 17, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Red blood cells, DNA

    For clonal hematopoiesis, epigenetics can be in driver’s seat

    BioWorld Science
    Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
  • Illustration of amyloid plaques in Alzheimer's disease

    Elixiron’s enrupatinib shows upbeat interim phase II AD results

    BioWorld
    Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
  • CAR T and red blood cells

    Viva in vivo! At EHA, in vivo CAR T data continues to impress

    BioWorld
    Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing